RBC Capital Maintains Outperform on Outset Medical, Lowers Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has maintained an Outperform rating on Outset Medical (NASDAQ:OM) but lowered the price target from $29 to $17.
October 13, 2023 | 1:48 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Outset Medical's price target has been lowered from $29 to $17 by RBC Capital, though the Outperform rating is maintained.
The lowering of the price target by RBC Capital indicates a potential decrease in the stock's value in the short term. However, the maintained Outperform rating suggests that the stock is still expected to outperform the market or its sector. This could lead to mixed reactions among investors, but the lowered price target is likely to have a more immediate impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100